๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Starting insulin therapy with basal insulin analog or premix insulin analog in T2DM: a pooled analysis of treat-to-target trials

โœ Scribed by Fonseca, Vivian; Davidson, Jaime; Home, Philip; Snyder, James; Jellinger, Paul; Dyhr Toft, Anders; Barnett, Anthony

Book ID
120031018
Publisher
Informa plc
Year
2010
Tongue
English
Weight
550 KB
Volume
26
Category
Article
ISSN
0300-7995

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

PDB54 COMPARISON OF TREATMENT COSTS BETW
PDB54 COMPARISON OF TREATMENT COSTS BETWEEN BASAL-SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE (GLA) AND BOT WITH INSULIN DETEMIR (DET) IN PATIENTS WITH TYPE 2 DIABETES (T2D): ECONOMIC EVALUATION BASED ON THE RESULTS OF THE INSULIN GLARGINE (LANTUSยฎ) VERSUS INSULIN DETEMIR (LEVEMIRยฎ) TREAT-TO-TARGET (L2T3) STUDY
โœ PK Schรคdlich; KC Koltermann; FW Dippel; EG Hagenmeyer; B Hรคussler ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 81 KB
Randomized, open-label, parallel-group e
Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: A noninferiority intensification substudy of the DURABLE trial
โœ William F. Miser; Richard Arakaki; Honghua Jiang; Jamie Scism-Bacon; Pamela W. A ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 873 KB